Literature DB >> 6616860

Serum glycosidases in diabetes mellitus in relation to the retinopathy and to the length of the disease.

M A Serrano, A Reglero, J A Cabezas, L C García Díez, J J Corrales, S de Castro, J M Miralles.   

Abstract

The following glycosidase activities in sera have been studied: alpha-D-mannosidase, beta-D-glucuronidase, N-acetyl-beta-D-galactosaminidase, alpha-D-galactosidase, beta-D-galactosidase, alpha-D-glucosidase, beta-D-glucosidase and beta-D-fucosidase, in diabetic patients in relation to the presence of microangiopathy, evident by retinopathy, and to the length of the disease. A significant increase of all the enzyme activities, except for alpha-D-galactosidase was found. These elevations were independent of the development of retinopathy and the duration of the diabetic process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616860     DOI: 10.1016/0009-8981(83)90229-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Increased serum N-acetyl-beta-D-glucosaminidase and alpha-D-mannosidase activities in obese subjects.

Authors:  J Corral; J M Miralles; I J García-Pascual; J J Corrales; A García-Sastre; E Villar
Journal:  Clin Investig       Date:  1992-10

2.  Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2-6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A.

Authors:  Cheuk-Lun Lee; Philip C N Chiu; Poh-Choo Pang; Ivan K Chu; Kai-Fai Lee; Riitta Koistinen; Hannu Koistinen; Markku Seppälä; Howard R Morris; Bérangère Tissot; Maria Panico; Anne Dell; William S B Yeung
Journal:  Diabetes       Date:  2011-02-07       Impact factor: 9.461

3.  Beneficial effects of tyrosol on altered glycoprotein components in streptozotocin-induced diabetic rats.

Authors:  Ramasamy Chandramohan; Settu Saravanan; Leelavinothan Pari
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.